Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on glycopeptide use in german university hospitals.
Kern WV, De With K, Gonnermann C, Strehl E, Bergner J, Höffken G, Dörje F, Daschner F, Steib-Bauert M, Haber M, Herrmann M, Hartmann M, Straube E, Bühner R, Rothe U, Salzberger B, Marre R, Kern P; Medical Antibiotic Use Surveillance and Evaluation. Kern WV, et al. Among authors: rothe u. Infection. 2004 Jun;32(3):157-62. doi: 10.1007/s15010-004-3159-0. Infection. 2004. PMID: 15188076
Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II).
de With K, Bergner J, Bühner R, Dörje F, Gonnermann C, Haber M, Hartmann M, Rothe U, Strehl E, Steib-Bauert M, Kern WV. de With K, et al. Among authors: rothe u. Int J Antimicrob Agents. 2004 Sep;24(3):213-8. doi: 10.1016/j.ijantimicag.2004.03.015. Int J Antimicrob Agents. 2004. PMID: 15325423
Hospital use of systemic antifungal drugs.
de With K, Steib-Bauert M, Knoth H, Dörje F, Strehl E, Rothe U, Maier L, Kern WV. de With K, et al. Among authors: rothe u. BMC Clin Pharmacol. 2005 Feb 10;5:1. doi: 10.1186/1472-6904-5-1. BMC Clin Pharmacol. 2005. PMID: 15703083 Free PMC article.
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses.
Einhauser S, Asam C, Weps M, Senninger A, Peterhoff D, Bauernfeind S, Asbach B, Carnell GW, Heeney JL, Wytopil M, Fuchs A, Messmann H, Prelog M, Liese J, Jeske SD, Protzer U, Hoelscher M, Geldmacher C, Überla K, Steininger P, Wagner R; CoVaKo Study group. Einhauser S, et al. EBioMedicine. 2024 Dec;110:105438. doi: 10.1016/j.ebiom.2024.105438. Epub 2024 Nov 9. EBioMedicine. 2024. PMID: 39522353 Free PMC article.
Predictors of improvement in disease activity in childhood and adolescent Crohn's disease: an analysis of age, localization, initial severity and drug therapy - data from the Saxon Registry for Inflammatory Bowel Disease in Children in Germany (2000-2014).
Weidner J, Zoch M, Kern I, Reinecke I, Bathelt F, Manuwald U, Peng Y, Henke E, Rothe U, Kugler J. Weidner J, et al. Among authors: rothe u. Eur J Pediatr. 2024 Oct;183(10):4363-4377. doi: 10.1007/s00431-024-05671-8. Epub 2024 Aug 3. Eur J Pediatr. 2024. PMID: 39096385 Free PMC article.
A systematic review and meta-regression on international trends in the incidence of ulcerative colitis in children and adolescents associated with socioeconomic and geographic factors.
Weidner J, Kern I, Reinecke I, Bathelt F, Manuwald U, Henke E, Zoch M, Rothe U, Kugler J. Weidner J, et al. Among authors: rothe u. Eur J Pediatr. 2024 Apr;183(4):1723-1732. doi: 10.1007/s00431-024-05428-3. Epub 2024 Jan 17. Eur J Pediatr. 2024. PMID: 38231235 Free PMC article.
90 results